LifeMD, Inc. (LFMD)
NASDAQ: LFMD · Real-Time Price · USD
4.570
-0.070 (-1.51%)
At close: Apr 27, 2026, 4:00 PM EDT
4.520
-0.050 (-1.09%)
After-hours: Apr 27, 2026, 7:18 PM EDT
LifeMD Revenue
In the year 2025, LifeMD had annual revenue of $194.06M with 25.34% growth. LifeMD had revenue of $46.87M in the quarter ending December 31, 2025, a decrease of -27.06%.
Revenue (ttm)
$234.96M
Revenue Growth
+10.65%
P/S Ratio
1.13
Revenue / Employee
$551,293
Employees
352
Market Cap
219.24M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 194.06M | 39.23M | 25.34% |
| Dec 31, 2024 | 154.82M | 2.28M | 1.49% |
| Dec 31, 2023 | 152.55M | 33.51M | 28.15% |
| Dec 31, 2022 | 119.03M | 26.16M | 28.16% |
| Dec 31, 2021 | 92.88M | 55.58M | 149.04% |
| Dec 31, 2020 | 37.29M | 24.83M | 199.10% |
| Dec 31, 2019 | 12.47M | 4.14M | 49.79% |
| Dec 31, 2018 | 8.32M | 4.64M | 126.09% |
| Dec 31, 2017 | 3.68M | -1.56M | -29.72% |
| Dec 31, 2016 | 5.24M | 4.02M | 329.80% |
| Dec 31, 2015 | 1.22M | 504.70K | 70.67% |
| Dec 31, 2014 | 714.16K | -94.21K | -11.65% |
| Dec 31, 2013 | 808.36K | 134.59K | 19.97% |
| Dec 31, 2012 | 673.78K | -70.05K | -9.42% |
| Dec 31, 2011 | 743.83K | -528.15K | -41.52% |
| Dec 31, 2010 | 1.27M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Evolent Health | 1.88B |
| TruBridge | 346.84M |
| Definitive Healthcare | 241.52M |
| Weave Communications | 239.02M |
| So-Young International | 217.80M |
| Spok Holdings | 139.71M |
| National Research | 137.39M |
| CareCloud | 120.50M |
LFMD News
- 15 hours ago - LifeMD to Report First Quarter 2026 Financial Results on May 6 - GlobeNewsWire
- 17 days ago - LifeMD® Now Offering Eli Lilly and Company's Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management - GlobeNewsWire
- 27 days ago - LifeMD Offers Novo Nordisk's Industry-First Wegovy® Telehealth Subscription Program - GlobeNewsWire
- 4 weeks ago - LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock - GlobeNewsWire
- 6 weeks ago - LifeMD Appoints Veteran Healthcare Finance Executive as Chief Financial Officer and Expands Leadership Team - GlobeNewsWire
- 7 weeks ago - LifeMD Earnings Call Transcript: Q4 2025 - Transcripts
- 7 weeks ago - LifeMD Reports Fourth Quarter and Full Year 2025 Results - GlobeNewsWire
- 7 weeks ago - LifeMD to Participate in Two Investor Conferences During March - GlobeNewsWire